These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 390211)

  • 1. Crescentic glomerulonephritis without immune deposits: clinicopathologic features.
    Stilmant MM; Bolton WK; Sturgill BC; Schmitt GW; Couser WG
    Kidney Int; 1979 Feb; 15(2):184-95. PubMed ID: 390211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of crescentic glomerulonephritis with membranous glomerulonephropathy: a report of three cases.
    Moorthy AV; Zimmerman SW; Burkholder PM; Harrington AR
    Clin Nephrol; 1976 Jul; 6(1):319-25. PubMed ID: 782751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation of membranous glomerulonephritis into crescentic glomerulonephritis with glomerular basement membrane antibodies. Serial determinations of anti-GBM before the transformation.
    Kurki P; Helve T; von Bonsdorff M; Törnroth T; Pettersson E; Riska H; Miettinen A
    Nephron; 1984; 38(2):134-7. PubMed ID: 6236378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etiology and Outcome of Crescentic Glomerulonephritis From a Single Center in China: A 10-Year Review.
    Chen S; Tang Z; Xiang H; Li X; Chen H; Zhang H; Hu W; Zeng C; Liu Z
    Am J Kidney Dis; 2016 Mar; 67(3):376-83. PubMed ID: 26388283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crescentic glomerulonephritis: immune vs. nonimmune mechanisms.
    Cohen AH; Border WA; Shankel E; Glassock RJ
    Am J Nephrol; 1981; 1(2):78-83. PubMed ID: 6758575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic spectrum of crescentic glomerulonephritis: a hospital-based study.
    Choudhury TA; Singh RG; ; Singh S; Singh TB; Rathore SS;
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):689-96. PubMed ID: 24821180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superimposed glomerular immune complexes in anti-glomerular basement membrane disease.
    Savige JA; Dowling J; Kincaid-Smith P
    Am J Kidney Dis; 1989 Aug; 14(2):145-53. PubMed ID: 2757019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does truly 'idiopathic' crescentic glomerulonephritis exist?
    Angangco R; Thiru S; Esnault VL; Short AK; Lockwood CM; Oliveira DB
    Nephrol Dial Transplant; 1994; 9(6):630-6. PubMed ID: 7970088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerulonephritis with coexistent immune deposits and antibasement membrane activity.
    Rajaraman S; Pinto JA; Cavallo T
    J Clin Pathol; 1984 Feb; 37(2):176-81. PubMed ID: 6363455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clinicopathologic Spectrum of Rapidly Progressive Glomerulonephritis Based on Glomerular Immune Deposition and Antineutrophil Cytoplasmic Antibody.
    Han F; Chen L; Le J; Choong P; Xu Y; Wang H; Chen J
    Appl Immunohistochem Mol Morphol; 2015; 23(10):704-10. PubMed ID: 26551339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis.
    Hind CR; Paraskevakou H; Lockwood CM; Evans DJ; Peters DK; Rees AJ
    Lancet; 1983 Feb; 1(8319):263-5. PubMed ID: 6130293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases.
    Haas M; Eustace JA
    Kidney Int; 2004 Jun; 65(6):2145-52. PubMed ID: 15149327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The differential diagnosis of crescentic glomerulonephritis. The pathology of specific lesions with prognostic implications.
    Spargo BH; Ordóñez NG; Ringus JC
    Hum Pathol; 1977 Mar; 8(2):187-204. PubMed ID: 15939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic membranous glomerulonephritis with crescents.
    Tateno S; Sakai T; Kobayashi Y; Shigematsu H
    Acta Pathol Jpn; 1981 Mar; 31(2):211-9. PubMed ID: 7020333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular capillary and endothelial cell injury is associated with the formation of necrotizing and crescentic lesions in crescentic glomerulonephritis.
    Fujita E; Nagahama K; Shimizu A; Aoki M; Higo S; Yasuda F; Mii A; Fukui M; Kaneko T; Tsuruoka S
    J Nippon Med Sch; 2015; 82(1):27-35. PubMed ID: 25797872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmapheresis in treatment of acute oligoanuria in crescentic glomerulonephritis.
    Grcevska L; Polenaković M; Stojkovski L; Polenaković H
    Artif Organs; 1998 Oct; 22(10):827-30. PubMed ID: 9790079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Crescentic glomerulonephritis].
    Esnault VL; Moreau A; Testa A; Besnier D
    Nephrol Ther; 2006 Dec; 2(7):446-60. PubMed ID: 17185236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features.
    Rosenstock JL; Markowitz GS; Valeri AM; Sacchi G; Appel GB; D'Agati VD
    Kidney Int; 2003 Apr; 63(4):1450-61. PubMed ID: 12631361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.